News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,419 Results
Type
Article (32392)
Company Profile (640)
Press Release (611387)
Multimedia
Podcasts (56)
Webinars (11)
Section
Business (196506)
Career Advice (2115)
Deals (36116)
Drug Delivery (103)
Drug Development (77516)
Employer Resources (164)
FDA (15169)
Job Trends (14615)
News (330987)
Policy (28569)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (1260)
Academic (1)
Accelerated approval (5)
Adcomms (16)
Allergies (83)
Alliances (46674)
ALS (94)
Alzheimer's disease (1296)
Antibody-drug conjugate (ADC) (141)
Approvals (15149)
Artificial intelligence (239)
Autoimmune disease (28)
Automation (13)
Bankruptcy (375)
Best Places to Work (10833)
BIOSECURE Act (22)
Biosimilars (98)
Biotechnology (437)
Bladder cancer (75)
Brain cancer (23)
Breast cancer (239)
Cancer (2051)
Cardiovascular disease (169)
Career advice (1745)
Career pathing (33)
CAR-T (150)
Cell therapy (419)
Cervical cancer (17)
Clinical research (63528)
Collaboration (826)
Compensation (521)
Complete response letters (28)
COVID-19 (2175)
CRISPR (39)
C-suite (250)
Cystic fibrosis (98)
Data (2028)
Decentralized trials (2)
Denatured (3)
Depression (48)
Diabetes (244)
Diagnostics (6290)
Digital health (17)
Diversity (3)
Diversity, equity & inclusion (37)
Drug discovery (112)
Drug pricing (101)
Drug shortages (24)
Duchenne muscular dystrophy (89)
Earnings (82762)
Editorial (37)
Employer branding (24)
Employer resources (140)
Events (108912)
Executive appointments (726)
FDA (16306)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (732)
Gene editing (105)
Generative AI (24)
Gene therapy (290)
GLP-1 (713)
Government (2852)
Grass and pollen (6)
Guidances (47)
Healthcare (15834)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (127)
Indications (28)
Infectious disease (2311)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (94)
Interviews (425)
IPO (17180)
IRA (42)
Job creations (4214)
Job search strategy (1447)
Kidney cancer (10)
Labor market (36)
Layoffs (534)
Leadership (19)
Legal (7111)
Liver cancer (69)
Lung cancer (291)
Lymphoma (138)
Machine learning (3)
Management (59)
Manufacturing (316)
MASH (65)
Medical device (13471)
Medtech (13476)
Mergers & acquisitions (19467)
Metabolic disorders (656)
Multiple sclerosis (79)
NASH (19)
Neurodegenerative disease (94)
Neuropsychiatric disorders (32)
Neuroscience (1830)
NextGen: Class of 2025 (5965)
Non-profit (1905)
Northern California (2607)
Now hiring (40)
Obesity (358)
Opinion (247)
Ovarian cancer (67)
Pain (87)
Pancreatic cancer (79)
Parkinson's disease (144)
Partnered (19)
Patents (232)
Patient recruitment (103)
Peanut (48)
People (56579)
Pharmaceutical (132)
Pharmacy benefit managers (16)
Phase I (20003)
Phase II (28413)
Phase III (21025)
Pipeline (1151)
Policy (134)
Postmarket research (1907)
Preclinical (8024)
Press Release (64)
Prostate cancer (97)
Psychedelics (36)
Radiopharmaceuticals (259)
Rare diseases (370)
Real estate (5684)
Recruiting (65)
Regulatory (20501)
Reports (35)
Research institute (1322)
Resumes & cover letters (330)
Rett syndrome (3)
RNA editing (4)
RSV (44)
Schizophrenia (74)
Series A (136)
Series B (89)
Service/supplier (26)
Sickle cell disease (52)
Southern California (2190)
Special edition (16)
Spinal muscular atrophy (145)
Sponsored (21)
Startups (3872)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (35)
The Weekly (52)
United States (22437)
Vaccines (643)
Venture capitalists (44)
Weight loss (241)
Women's health (24)
Worklife (18)
Date
Today (92)
Last 7 days (653)
Last 30 days (2307)
Last 365 days (32948)
2025 (9950)
2024 (35514)
2023 (40248)
2022 (50368)
2021 (53519)
2020 (50519)
2019 (41710)
2018 (31895)
2017 (32337)
2016 (30457)
2015 (35846)
2014 (28506)
2013 (23511)
2012 (25083)
2011 (25262)
2010 (23127)
Location
Africa (665)
Alabama (58)
Alaska (6)
Arizona (158)
Arkansas (11)
Asia (39773)
Australia (6483)
California (5997)
Canada (1954)
China (517)
Colorado (261)
Connecticut (273)
Delaware (135)
Europe (86803)
Florida (854)
Georgia (200)
Hawaii (1)
Idaho (55)
Illinois (448)
India (28)
Indiana (315)
Iowa (12)
Japan (151)
Kansas (98)
Kentucky (23)
Louisiana (11)
Maine (65)
Maryland (736)
Massachusetts (4624)
Michigan (229)
Minnesota (386)
Mississippi (2)
Missouri (80)
Montana (30)
Nebraska (22)
Nevada (58)
New Hampshire (65)
New Jersey (1699)
New Mexico (30)
New York (1669)
North Carolina (1039)
North Dakota (6)
Northern California (2607)
Ohio (182)
Oklahoma (10)
Oregon (40)
Pennsylvania (1303)
Puerto Rico (11)
Rhode Island (34)
South America (1055)
South Carolina (21)
South Dakota (1)
Southern California (2190)
Tennessee (83)
Texas (869)
Utah (174)
Virginia (141)
Washington D.C. (58)
Washington State (563)
West Virginia (3)
Wisconsin (48)
644,419 Results for "bristol myers squibb company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bristol Myers Squibb Reports First Quarter Financial Results for 2025
April 24, 2025
·
19 min read
Press Releases
Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb
April 24, 2025
·
6 min read
Press Releases
Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial
April 14, 2025
·
15 min read
Press Releases
Bristol Myers Squibb Announces Dividend - March 3, 2025
March 3, 2025
·
1 min read
Press Releases
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
March 4, 2025
·
4 min read
Press Releases
Bristol Myers Squibb to Participate in Upcoming March 2025 Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025
March 13, 2025
·
1 min read
Press Releases
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb
March 11, 2025
·
19 min read
Press Releases
Bristol Myers Squibb Announces Topline Results from Phase 3 ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia
April 23, 2025
·
15 min read
Biotech Bay
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb
Scenic Biotech announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb’s drug targets by identifying target biology for indication selection and expansion.
April 30, 2024
·
2 min read
1 of 64,442
Next
